Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Beigene Ltd (BGNE)  
$153.58 5.02 (3.38%) as of 4:30 Fri 4/26


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 90,630,000
Market Cap: 13.92(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $129.52 - $265
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  664
Guru Rank Value     : 3
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   BeiGene is a commercial-stage biotechnology company focused on developing and commercializing molecularly-targeted and immuno-oncology cancer therapeutics. Co.'s clinical-stage drug candidates include: Zanubrutinib, which is a small molecule inhibitor of Bruton's tyrosine kinase for the treatment of mantle cell lymphoma in adult patients; Tislelizumab, which is a humanized monoclonal antibody against the immune checkpoint receptor programmed cell death protein 1; Pamiparib (BGB-290), which is for the treatment of various solid tumors; and Lifirafenib, which is an investigational small molecule inhibitor with RAF monomer and dimer inhibition activities.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 100,397 1,200,397 5,371,251 5,588,274
Total Sell Value $15,909,372 $214,459,372 $1,041,558,017 $1,085,894,829
Total People Sold 2 3 8 9
Total Sell Transactions 6 7 21 54
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 241
  Page 4 of 10  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Huang Jane CMO, Hematology   •       –      –    2021-05-31 4 A $0.00 $0 D/D 7,189 292,772     -
   Huang Jane CMO, Hematology   •       –      –    2021-05-28 4 AS $352.85 $534,453 D/D (1,500) 0 -5%     
   Huang Jane CMO, Hematology   •       –      –    2021-05-28 4 OE $29.49 $44,235 D/D 1,500 1,500     -
   Glazer Donald W. Director   –       •      –    2021-05-27 4 GD $0.00 $0 D/D 4,700 2,823,129     -
   Wang Xiaodong Chair, Scientific Advisory Brd   –       •      –    2021-05-10 4 S $299.40 $1,019,752 D/D (3,394) 0 -33%     
   Wang Xiaodong Chair, Scientific Advisory Brd   –       •      –    2021-05-10 4 OE $0.13 $441 D/D 3,394 3,394     -
   Wang Xiaodong Chair, Scientific Advisory Brd   –       •      –    2021-05-10 4 OE $0.13 $5,734 D/D 44,109 5,747,271     -
   Wu Xiaobin President, COO & GM China   •       –      –    2021-05-03 4 S $343.00 $2,303,245 D/D (6,715) 0 -4%     
   Huang Jane CMO, Hematology   •       –      –    2021-04-29 4 AS $350.25 $532,387 D/D (1,500) 0 -4%     
   Huang Jane CMO, Hematology   •       –      –    2021-04-29 4 OE $29.49 $44,235 D/D 1,500 1,500     -
   Wang Lai Global Head of R&DOfficer   •       –      –    2021-04-01 3 IO $0.00 $0 D/D 0 203,983 -18%     
   Huang Jane CMO, Hematology   •       –      –    2021-03-29 4 AS $321.94 $485,993 D/D (1,500) 0 -1%     
   Huang Jane CMO, Hematology   •       –      –    2021-03-29 4 OE $29.49 $44,235 D/D 1,500 1,500     -
   Glazer Donald W. Director   –       •      –    2021-03-12 4 GD $0.00 $0 D/D 80,000 2,827,829     -
   Huang Jane CMO, Hematology   •       –      –    2021-02-26 4 AS $315.62 $481,099 D/D (1,500) 0 0%     
   Huang Jane CMO, Hematology   •       –      –    2021-02-26 4 OE $29.49 $44,235 D/D 1,500 1,500     -
   Huang Jane CMO, Hematology   •       –      –    2021-01-29 4 AS $318.48 $484,492 D/D (1,500) 0 10%     
   Huang Jane CMO, Hematology   •       –      –    2021-01-29 4 OE $29.49 $44,235 D/D 1,500 1,500     -
   Liang Howard CFO & Chief Strategy Officer   •       –      –    2021-01-15 4 AS $344.38 $4,345,689 D/D (12,600) 0 2%     
   Liang Howard CFO & Chief Strategy Officer   •       –      –    2021-01-15 4 OE $6.50 $81,900 D/D 12,600 12,600     -
   Liang Howard CFO & Chief Strategy Officer   •       –      –    2021-01-14 4 AS $344.28 $482,256 D/D (1,400) 0 3%     
   Liang Howard CFO & Chief Strategy Officer   •       –      –    2021-01-14 4 OE $6.50 $9,100 D/D 1,400 1,400     -
   Baker Julian Director   –       •       •   2021-01-04 4 S $220.50 $26,714,457 I/I (121,154) 10,699,954 -18%     
   Huang Jane CMO, Hematology   •       –      –    2020-12-29 4 AS $244.90 $373,690 D/D (1,500) 0 24%     
   Huang Jane CMO, Hematology   •       –      –    2020-12-29 4 OE $29.49 $44,235 D/D 1,500 1,500     -
  241 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 4 of 10
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us